MedPath

A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty

Not Applicable
Completed
Conditions
Analgesia in Total Knee Arthroplasty
Interventions
Procedure: Adductor Canal Block
Registration Number
NCT02104934
Lead Sponsor
Changi General Hospital
Brief Summary

Total knee arthroplasty or replacement (TKA), a commonly performed surgery for osteoarthritis of the knee, is a painful procedure and requires a multimodal analgesic approach. A method for analgesia is local infiltration analgesia (LIA), where a mixture of drugs is injected around the knee joint.

Adductor canal block (ACB) is an alternative regional anaesthesia technique which has been shown to result in minimal thigh weakness.

The investigators aim to study if the analgesia provided by ACB is superior to LIA while preserving quadriceps strength.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients scheduled for primary TKA under single shot spinal anaesthesia, between ages 45-85 years old, American Society of Anesthesiologists (ASA) physical status 1 to 3 and BMI 18-35 kg/m2
Exclusion Criteria
  • Patients unable to give consent, inability to communicate/ cooperate, patients with regular consumption of strong opioids (morphine, oxycodone) or steroids, allergy to local anaesthetics or any drugs included in the study, patients with lower limb surgery in the preceding year, patients with pre-existing neurological deficits and patients who have contraindications for spinal anaesthesia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adductor Canal BlockAdductor Canal BlockThe Adductor Canal Block group of patients will receive intravenous ketorolac 30mg intra-operatively and an adductor canal block at the end of surgery. The block will be performed under real time ultrasound guidance and 30mls of 0.5% ropivacaine (150mg) is injected with a Stimuplex A100, 21G needle.
Primary Outcome Measures
NameTimeMethod
Morphine consumption in the first 24 hours24 hours

morphine consumption in the first 24 hours (including morphine administered in recovery and via PCA).

Secondary Outcome Measures
NameTimeMethod
Sedation ScoresUp to 48 hours
Quadriceps Strengthat 24 and 48 hours
Morphine ConsumptionAt 48 hours

The balance usage after primary outcome

Pain Scores1, 6, 12, 24 hours; up to 48 hours postoperative

Pain scores are recorded at 1, 6, 12, 24 and 48 hours post-operatively, assessed using a visual analog scale (0-100mm) at rest and during 45 degree passive flexion of knee.

Postoperative Nausea and VomitingUp to 48 hours

Presence/absence of nausea and vomiting, and total number of episodes of vomiting

Trial Locations

Locations (1)

Changi General Hospital

πŸ‡ΈπŸ‡¬

Singapore, Singapore

Β© Copyright 2025. All Rights Reserved by MedPath